Hepatita autoimună în sarcină: prezentare de caz

Authors:

Abstract
Autoimmune hepatitis (AIH) is a progressive chronic liver disease of unknown cause, with varied clinical picture and evolution. The diagnosis of autoimmune hepatitis is based on histological changes (interface hepatitis), characteristic clinical and biological signs (hypertransaminasemia and increased serum IgG concentration), with the presence of one or more characteristic autoantibodies. The purpose of this presentation was to analyze the evolution of the disease of a patient with autoimmune hepatitis during pregnancy, the safety of the treatment, and the long-term results/complications of immunosuppressive therapy. During this period, the patient periodically stopped the treatment, had a pregnancy that ended with the intrauterine death of the fetus, and then managed to give birth to a healthy child. Predniso(lo)n as initial therapy, followed by the addition of azathioprine after two weeks, are the first-line treatment for AIH, including in pregnancy. In our patient, immunosuppressive therapy with prednisone and azathioprine was safe and effective in inducing and maintaining remission, without significant complications or exacerbation during the pregnancy. Thus, an early established diagnosis and the prompt application of appropriate treatment, strict monitoring of the disease and of immunosuppressive treatment complications, can improve the evolution of AIH, slowing the progression of the disease.

This publication has 10 references indexed in Scilit: